OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why Great Mitotic Inhibitors Make Poor Cancer Drugs
Victoria C. Yan, Hannah E. Butterfield, Anton H. Poral, et al.
Trends in cancer (2020) Vol. 6, Iss. 11, pp. 924-941
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Cell cycle control in cancer
Helen K. Matthews, Cosetta Bertoli, Robertus A.M. de Bruin
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 74-88
Open Access | Times Cited: 981

Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Patrick Flynn, Peter D. Koch, Timothy J. Mitchison
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 48
Open Access | Times Cited: 85

Paclitaxel resistance related to nuclear envelope structural sturdiness
Elizabeth R. Smith, Jing‐Quan Wang, Dong‐Hua Yang, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100881-100881
Closed Access | Times Cited: 51

Cell death in cancer chemotherapy using taxanes
Ana P. Xu, Lucy B. Xu, Elizabeth R. Smith, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12

Targeting chromosomally unstable tumors with a selective KIF18A inhibitor
Aaron F. Phillips, Rumin Zhang, Mia Jaffe, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

The Second Selectivity of Taxanes to Malignant Cells --- Nuclear Envelope Malleability
Xiang‐Xi Xu, Elizabeth R. Smith
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1051-1053
Open Access | Times Cited: 1

Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
Kenneth J. Pienta, Emma U. Hammarlund, Robert H. Austin, et al.
Seminars in Cancer Biology (2020) Vol. 81, pp. 145-159
Open Access | Times Cited: 66

Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer
Francesco Naso, Dalila Boi, Camilla Ascanelli, et al.
Oncogene (2021) Vol. 40, Iss. 23, pp. 3917-3928
Open Access | Times Cited: 52

BRD4 in physiology and pathology: ‘‘BET’’ on its partners
Yin Liang, Jieyi Tian, Tao Wu
BioEssays (2021) Vol. 43, Iss. 12
Closed Access | Times Cited: 52

Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 51

Novel insights in cell cycle dysregulation during prostate cancer progression
Salma Ben‐Salem, Varadha Balaji Venkadakrishnan
Endocrine Related Cancer (2021) Vol. 28, Iss. 6, pp. R141-R155
Open Access | Times Cited: 34

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
Yu-Fei Cao, Lei Xie, Bei-Bei Tong, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 527-543
Open Access | Times Cited: 25

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets
Sibylle Haid, Alina Matthaei, Melina Winkler, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 3
Open Access | Times Cited: 4

Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity
Elizabeth R. Smith, Justin Leal, Celina Amaya, et al.
Molecular and Cellular Biology (2021) Vol. 41, Iss. 7
Open Access | Times Cited: 26

Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids
Miguel A. Lasunción, Javier Martínez‐Botas, Covadonga Martín-Sánchez, et al.
Biochemical Pharmacology (2021) Vol. 196, pp. 114623-114623
Closed Access | Times Cited: 26

Roles and regulation of Haspin kinase and its impact on carcinogenesis
Roberto Quadri, Sarah Sertic, Marco Muzi-Falconi
Cellular Signalling (2022) Vol. 93, pp. 110303-110303
Open Access | Times Cited: 19

Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability
Jessica R. Bobbitt, Leslie Cuellar-Vite, Kristen L. Weber-Bonk, et al.
Journal of Biological Chemistry (2025), pp. 108196-108196
Open Access

OSMOTIC STRESS INFLUENCES MICROTUBULE DRUG RESPONSE VIA WNK1 KINASE SIGNALING
Ana Monfort‐Vengut, Natalia Sanz‐Gómez, Sandra Ballesteros-Sánchez, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101203-101203
Closed Access

The Persistent Power of the Taxane/Platin Chemotherapy
Lucy B. Xu, Elizabeth R. Smith, Vasili Koutouratsas, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1208-1208
Open Access

Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics
Sajid Asghar, Radu Iliescu, Rareş Ştiufiuc, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3820-3820
Open Access

Targeting HASPIN in gemcitabine-resistant pancreatic cancer cells by lead optimization of thioadenosine analogue
Yoon-Ze Shin, Yun A Yum, Eun Seo Bae, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 188, pp. 118135-118135
Closed Access

Breaking malignant nuclei as a non-mitotic mechanism of taxol-paclitaxel
Elizabeth R. Smith, Xiang‐Xi Xu
Journal of Cancer Biology (2021) Vol. 2, Iss. 4
Open Access | Times Cited: 22

Use of Drug Sensitisers to Improve Therapeutic Index in Cancer
Yushan Chen, Enhui Jin, Philip J. Day
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 928-928
Open Access | Times Cited: 3

Supramolecular Chemical Biology: Designed Receptors and Dynamic Chemical Systems
Ignacio Alfonso
Chemical Communications (2024) Vol. 60, Iss. 72, pp. 9692-9703
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top